➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Mallinckrodt
AstraZeneca
Boehringer Ingelheim
Merck

Last Updated: July 8, 2020

DrugPatentWatch Database Preview

Litigation Details for Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc. (D. Del. 2014)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc. (D. Del. 2014)

Docket   Start Trial Date Filed 2014-02-27
Court District Court, D. Delaware Date Terminated 2016-02-29
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To
Parties WATSON LABORATORIES INC.
Patents 7,601,758; 7,619,004; 7,820,681; 7,906,519; 7,915,269; 7,935,731; 7,964,647; 7,964,648; 7,981,938; 8,093,296; 8,093,297; 8,093,298; 8,097,655; 8,415,395; 8,415,396; 8,440,721; 8,440,722
Attorneys Amy L. Greywitt
Link to Docket External link to docket
Small Molecule Drugs cited in Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-02-27 1 Page|D #: 6 l\/l. United States Patent Number 8,440,721 (“the ‘721 Patent”), entitled “METHODS FOR CONCOMITANT…722 Patents are collectively referred to herein as the “Patents.” l6. Takeda has submitted patent information…of COLCRYS®. A. United Sates Patent Number 7,619,004 (“the ‘004 Patent”), entitled “METHODS FOR CONCOMITANT…the inventor. B. United States Patent Number 7,6()1,758 (“the ‘758 Patent”), entitled “METHODS FOR CONCOMITANT…Page|D #: 4 C. United States Patent Number 7,820,681 (“the ‘681 Patent”), entitled “METHODS FOR CONCOMITANT External link to document
2014-06-23 29 Takeda Patent Claimed Methods Proposed Amended Complaint U.S. Patent 7,906,519 Treatment of FMF…Watson wins this patent litigation with respect to the FMF patents 1f the Orange Book patents for Watson’s…PROCEEDING This is a patent infringement lawsuit involving several Takeda patents that purport to cover…Goggin Ex. 7.) These patent applications ultimately matured into the 17 patents that Takeda seeks to …FMF Count 1 U.S. Patent 7,935,731 Treatment of FMF Count 11 U.S. Patent 8,093,298 Treatment of FMF Count External link to document
2014-09-04 36 19, ex. 1 at~ 17)3 Fourteen patents- U.S. Patent Nos. 7,619,004; 7,601 ,758; 7,820,681; 7,915,269; 7,964,647…gout (the "gout patents"). (/d. at~ 15) Five patents- U.S. Patent Nos. 7,906,519; 7,935…,648 ("the '648 patent"), and 8,093,297 ("the 297 patent")- include claims directed…7,935, 731; 8,093,298; the '648 patent; and the 297 patent- include claims directed to the treatment…FMF (the "FMF patents"). (/d. at ~ 14) The '648 and '297 patents include claims directed External link to document
2014-09-04 37 G. United States Patent Number 7,601,758 (“the ‘758 Patent”), entitled “METHODS FOR CONCOMITANT… A. United Sates Patent Number 7,906,519 (“the ‘519 Patent”), entitled “METHODS FOR CONCOMITANT… B. United States Patent Number 7,935,731 (“the ‘731 Patent”), entitled “METHODS FOR CONCOMITANT… C. United States Patent Number 8,093,298 (“the ‘298 Patent”), entitled “METHODS FOR CONCOMITANT… D. United States Patent Number 7,964,648 (“the ‘648 Patent”), entitled “METHODS FOR CONCOMITANT External link to document
2014-09-09 38 ,964,648; 7,619,004; 7,601,758; 7,820,681; 7,906,519; 7,935,731; 8,093,298; 7,915,269; 7,964,647; 7,981,938… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,093,297; 7,964,648… 29 February 2016 1:14-cv-00268 830 Patent None District Court, D. Delaware External link to document
2014-02-27 4 US 8,097,655; US 8,415,395; US 8,415,396; US 8,440,721; US 8,440,722. (cla, ) (Entered: 02/27/2014) … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,619,004; … 29 February 2016 1:14-cv-00268 830 Patent None District Court, D. Delaware External link to document
2014-09-22 41 the ’297 Patent”), 7,619,004 (“the ’004 Patent”), US. Patent No. 7,601,758 (“the ’75 8 Patent”), U.S. …October 13, 2009, the PTO issued U.S. Patent No. 7,601,758 (“the ’758 patent”), entitled on its face “METHODS…’758 patent, the ’681 Patent, the ’269 Patent, the ’647 Patent, the ’938 Patent, the ’296 Patent, the …U.S. Patent No. 8,093,298 (“the ’298 patent”), U.S. Patent 7,964,648 (“the ’648 Patent”), U.S. Patent No…’519 patent, the ’731 patent, the ’298 patent, the ’648 patentj the ’297 patent, the ’004 Patent, the External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
McKesson
Baxter
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.